Close Menu

NEW YORK (GenomeWeb) – Fluidigm and Visiopharm have signed a comarketing agreement to automate image analysis for imaging mass cytometry, the companies said today.

Under the agreement, Fluidigm and Visiopharm will copromote Visiopharm's Phenomap image-analysis software alongside Fluidigm's Hyperion imaging system, MCD Viewer software, and related Maxpar antibodies and kits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.

A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.

Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.

In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.